Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
October 9, 2025
Halia Therapeutics has been named one of the Top 10 Longevity Breakthrough Award Winners for 2025. This recognition reflects Halia’s mission to redefine human potential by addressing the root cause of chronic diseases: inflammation. Congratulations Halia!
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
